IMMU not only has Lupus best in class but a cancer pipeline. I expect a UCB buyout.. and give the Sullivan's a golden farewell.
Expected PPS after positive data? I say 12.
On-going safety study may prove 12-17 will be ok .... FDA is conservative.. All will be well.. Asthma is big indication to get in adults.. Do we see a pop tomorrow?
I thought I heard 2Q
I feel a run up... then bam with all of the shorts... wow.. THEY GOT A PATENT until 2034 and EU approval will cement the ride up.. then BO.. booyah
stat significant for a almost 50% reduction for 25% of study population.... EU approval coming and wow!!
buy now.. tomorrow 10 bucks
Sentiment: Strong Buy